Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Immunogen Inc
(NQ:
IMGN
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EST, Feb 9, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Immunogen Inc
< Previous
1
2
...
6
7
8
9
10
11
12
13
Next >
ImmunoGen Announces Conference Call to Discuss Its First Quarter 2022 Operating Results
April 21, 2022
From
ImmunoGen Inc.
Via
Business Wire
12 Health Care Stocks Moving In Thursday's After-Market Session
April 14, 2022
Gainers
Via
Benzinga
ImmunoGen Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
April 01, 2022
From
ImmunoGen, Inc.
Via
Business Wire
Why Are ImmunoGen Shares Trading Lower Today
March 21, 2022
ImmunoGen Inc (NASDAQ: IMGN)
Via
Benzinga
ImmunoGen Announces Webcast of Panel Discussion at Upcoming Canaccord Genuity Horizons in Oncology Virtual Conference
March 31, 2022
From
ImmunoGen, Inc.
Via
Business Wire
The Daily Biotech Pulse: Sanofi-IGM Ink Antibody Drug Collaboration; NeoGenomics Sinks On CEO Departure, Q1 Warning; Decision Day For Akebia
March 29, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
ImmunoGen Submits Biologics License Application to the US Food and Drug Administration for Mirvetuximab Soravtansine in Ovarian Cancer
March 29, 2022
From
ImmunoGen, Inc.
Via
Business Wire
75 Biggest Movers From Yesterday
March 22, 2022
Gainers NeuroSense Therapeutics Ltd. (NASDAQ: NRSN) shares jumped 299.4% to close at $6.23 on Monday as the company received clearance from the FDA to initiate a pharmacokinetic...
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
March 21, 2022
Gainers
Via
Benzinga
Stocks That Hit 52-Week Lows On Monday
March 21, 2022
During Monday's session, 39 stocks hit new 52-week lows. Interesting Facts About Today's 52-Week Lows: The largest company in terms of market cap to set a...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 21, 2022
March 21, 2022
Upgrades According to B. Riley Securities, the prior rating for BRT Apartments Corp (NYSE:BRT) was changed from Neutral to Buy. BRT Apartments earned $0.41 in the fourth quarter,...
Via
Benzinga
46 Stocks Moving In Monday's Mid-Day Session
March 21, 2022
Gainers NeuroSense Therapeutics Ltd. (NASDAQ: NRSN) climbed 369% to $7.32 as the company received clearance from the FDA to initiate a pharmacokinetic study of PrimeC in...
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
March 21, 2022
Gainers Corbus Pharmaceuticals (NASDAQ:CRBP) shares increased by 20.3% to $0.4 during Monday's pre-market session. The market value of their outstanding shares is at $49.7 million.
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
March 21, 2022
Welcome back, investor! We're getting right into the thick of it with a look at the biggest pre-market stock movers for Monday!
Via
InvestorPlace
28 Stocks Moving in Monday's Pre-Market Session
March 21, 2022
Gainers BitNile Holdings, Inc. (NYSE: NILE) rose 61.1% to $0.90 in pre-market trading. BitNile's TurnOnGreen resumed expansion of its electric vehicle charging network and e-...
Via
Benzinga
ImmunoGen Presents Full Results from Positive Pivotal SORAYA Trial of Mirvetuximab Soravtansine in Ovarian Cancer at SGO Annual Meeting
March 19, 2022
From
ImmunoGen, Inc.
Via
Business Wire
The Daily Biotech Pulse: Lilly's Jardiance Gets Nod For Heart Failure, Pulmatrix Announces Reverse Split, Reata Awaits FDA Decision
February 25, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Lilly's Co-developed Diabetes Drug Jardiance Gets Label Expansion To...
Via
Benzinga
Immunogen: Q4 Earnings Insights
February 25, 2022
Immunogen (NASDAQ:IMGN) reported its Q4 earnings results on Friday, February 25, 2022 at 06:30 AM. Here's what investors need to know about the announcement. Earnings...
Via
Benzinga
ImmunoGen Reports Recent Progress and 2021 Financial Results
February 25, 2022
From
ImmunoGen Inc.
Via
Business Wire
Earnings Scheduled For February 25, 2022
February 25, 2022
Companies Reporting Before The Bell • ACM Research (NASDAQ:ACMR) is estimated to report quarterly earnings at $0.64 per share on revenue of $89.53 million. •...
Via
Benzinga
Earnings Outlook For Immunogen
February 24, 2022
Immunogen (NASDAQ:IMGN) is set to give its latest quarterly earnings report on Friday, 2022-02-25. Here's what investors need to know before the announcement. Analysts estimate...
Via
Benzinga
ImmunoGen Announces Webcast of Panel Discussion at Upcoming Cowen 42nd Annual Health Care Conference
February 23, 2022
From
ImmunoGen, Inc.
Via
Business Wire
Lilly Unites With ImmunoGen In ADC Deal Worth Up To $1.7B
February 15, 2022
ImmunoGen Inc (NASDAQ: IMGN) has struck a multi-target license deal with Eli Lilly And Co (NYSE: LLY) to grant exclusive rights to research, develop, and...
Via
Benzinga
ImmunoGen Announces a Global, Multi-Target License Agreement of its Novel Camptothecin ADC Platform to Lilly for Up to $1.7 Billion
February 15, 2022
From
ImmunoGen Inc.
Via
Business Wire
The Week Ahead In Biotech (Feb. 20-26): Reata Awaits FDA Decision, Bausch Health, Moderna Lead Earnings News Flow
February 20, 2022
Biotech stock extended lower for a second straight week as risk aversion continued to pressure stocks amid geopolitical tensions and macroeconomic worries. On the regulatory front...
Via
Benzinga
ImmunoGen Announces Conference Call to Discuss Its 2021 Operating Results
February 10, 2022
From
ImmunoGen Inc.
Via
Business Wire
ImmunoGen Announces Webcast of Presentation and Q&A at Upcoming SVB Leerink 11th Annual Global Healthcare Conference
February 04, 2022
From
ImmunoGen, Inc.
Via
Business Wire
ImmunoGen Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
February 01, 2022
From
ImmunoGen Inc.
Via
Business Wire
ImmunoGen Appoints Mimi Huizinga, MD, as Senior Vice President and Head of Medical Affairs
January 31, 2022
From
ImmunoGen Inc.
Via
Business Wire
Sutro Biopharma Collapses; Why One Analyst Remains Bullish On Its Chances In Cancer
January 06, 2022
Sutro Biopharma could still find a place for itself in ovarian cancer treatment.
Via
Investor's Business Daily
< Previous
1
2
...
6
7
8
9
10
11
12
13
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.